Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Aguilar Salinas

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Atherosclerosis|December 23, 1998
Metabolic modes of action of the statins in the hyperlipoproteinemiasC A Aguilar-Salinas, H Barrett, G Schonfeld
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 10, 2000
[Limitations of the diagnostic criteria for type 2 diabetes and glucose intolerance]C A Aguilar Salinas, F J Gómez Pérez, J A Rull
Journal of Lipid Research|April 1, 1996
Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotesK G Parhofer, P H Barrett, C A Aguilar-Salinas, et al.
Journal of Lipid Research|January 1, 1995
Physiologic mechanisms of action of lovastatin in nephrotic syndromeC A Aguilar-Salinas, P H Barrett, J Kelber, et al.
Diabetes, Nutrition & Metabolism|March 6, 2004
The combination metformin/glyburide exerts its hypoglycemic effect mainly by increasing insulin secretion: a controlled, randomized, double-blind, crossover studyA Gulias-Herrero, C A Aguilar-Salinas, F J Gómez-Pérez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1997
A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapyC A Aguilar-Salinas, P Hugh, R Barrett, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 16, 2020
The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetesN E Antonio-Villa, O Y Bello-Chavolla, A Vargas-Vázquez, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|October 1, 1991
[The transfer of critically ill patients]J E Cortés Franco, G Gamba Ayala, C A Aguilar Salinas, et al.
Public Health|December 6, 2023
Trends in the mortality of diabetes in Mexico from 1998 to 2022: a joinpoint regression and age-period-cohort effect analysisR Rojas-Martínez, C Escamilla-Nuñez, C A Aguilar-Salinas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1995
Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein BC A Aguilar-Salinas, P H Barrett, K G Parhofer, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Atherosclerosis|December 23, 1998
Metabolic modes of action of the statins in the hyperlipoproteinemiasC A Aguilar-Salinas, H Barrett, G Schonfeld
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 10, 2000
[Limitations of the diagnostic criteria for type 2 diabetes and glucose intolerance]C A Aguilar Salinas, F J Gómez Pérez, J A Rull
Journal of Lipid Research|April 1, 1996
Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotesK G Parhofer, P H Barrett, C A Aguilar-Salinas, et al.
Journal of Lipid Research|January 1, 1995
Physiologic mechanisms of action of lovastatin in nephrotic syndromeC A Aguilar-Salinas, P H Barrett, J Kelber, et al.
Diabetes, Nutrition & Metabolism|March 6, 2004
The combination metformin/glyburide exerts its hypoglycemic effect mainly by increasing insulin secretion: a controlled, randomized, double-blind, crossover studyA Gulias-Herrero, C A Aguilar-Salinas, F J Gómez-Pérez, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1997
A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapyC A Aguilar-Salinas, P Hugh, R Barrett, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 16, 2020
The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetesN E Antonio-Villa, O Y Bello-Chavolla, A Vargas-Vázquez, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|October 1, 1991
[The transfer of critically ill patients]J E Cortés Franco, G Gamba Ayala, C A Aguilar Salinas, et al.
Public Health|December 6, 2023
Trends in the mortality of diabetes in Mexico from 1998 to 2022: a joinpoint regression and age-period-cohort effect analysisR Rojas-Martínez, C Escamilla-Nuñez, C A Aguilar-Salinas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1995
Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein BC A Aguilar-Salinas, P H Barrett, K G Parhofer, et al.
Pageof 4